Two studios that can barely greenlight one hit just merged on the condition they make 30 films a year. If they fail, the government auctions off their back lot to a real estate developer. This is either genius regulation or a punchline with a $110 billion price tag.

California's AG is leaving the door open to talks — but says any settlement would demand major structural changes, not a quick fix. With a trial date set for March 2027 and Paramount threatening to fight all the way to the Supreme Court, this merger is far from a done deal.

Publisher's parent shed 22 million monthly visitors last quarter; RE/MAX brings 149,267 agents and a pending sale to Real. Who sells the ads inside the new hub?

Publisher's parent shed 22 million monthly visitors last quarter; RE/MAX brings 149,267 agents and a pending sale to Real. Who sells the ads inside the new hub?

JCDecaux SE and JOJ Media House Group announce termination of planned consolidation in Slovakia's outdoor advertising market.

JCDecaux SE and JOJ Media House Group announce termination of planned consolidation in Slovakia's outdoor advertising market.

JCDecaux SE and JOJ Media House Group announce termination of planned consolidation in Slovakia's outdoor advertising market.

Ryvyl shareholders approved the RTB Digital merger on Apr 2, 2026; vote clears the key corporate hurdle and targets a Q2 2026 close, per Investing.com.

Court halts Nexstar–Tegna merger on Mar 28, 2026; $8.6B headline deal and ~64 Tegna stations face legal pause, raising retransmission and ad-revenue risk for broadcasters.

Helix Energy's Q1 2026 merger plans are discussed alongside past tech issues with Helix TV on LG WebOS TVs since 2018.

When Elon Musk announced that his AI startup, xAI, had acquired his social media company, X (formerly known as Twitter), in an all-stock deal, it raised some eyebrows. But in many ways, the deal made...

Continuous software delivery startup Harness Inc. announced a merger today with application programming interface security startup Traceable Inc., which will bring its cybersecurity technology to the...

Investing.com -- The U.K.’s Competition and Markets Authority (CMA) has launched a Phase 1 investigation into Primary Health Properties Plc’s £1.8 billion acquisition of Assura Plc, the regulator said on Wednesday. The inquiry will assess whether the deal could substantially lessen competition in any market in the United Kingdom. The initial review period begins on September 4 and runs until October 29, the CMA said. By the end of this period, the authority will decide whether to refer to the merger for a more detailed Phase 2 investigation. The CMA did not provide additional information on potential competition concerns. The acquisition became unconditional in August 2025 after a protracted takeover battle. Assura’s board had initially recommended a £1.7 billion cash offer from U.S.-based private equity firms KKR and Stonepeak Partners. However, following shareholder feedback, the board shifted its recommendation to PHP’s £1.8 billion offer, which combined cash and shares while maintaining Assura’s listing on the London Stock Exchange. Major institutional investors, including Schroders, Baillie Gifford, and Aberdeen, supported the PHP bid for its long-term sector exposure and the stability provided by government-backed healthcare assets. Assura, headquartered in Altrincham, Greater Manchester, operates over 600 healthcare properties across the U.K., including general practitioner and primary healthcare facilities. PHP, based in London, manages a portfolio of more than 500 similar properties in the U.K. and Ireland. The merger is intended to create a larger healthcare-focused real estate investment trust, leveraging government plans for long-term investment in the National Health Service. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. As of late August, PHP held a 92.02% stake in Assura, reflecting the near-finalization of the acquisition. With AGRP making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed AGRP alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including AGRP, could offer substantial returns as the market corrects. In 2025 alone, our AI identified several undervalued stocks that later surged by 50% or more. Is AGRP poised for similar growth? Don't miss the opportunity to find out.

MILAN (Reuters) -Leading governance adviser Glass Lewis on Wednesday confirmed its recommendation to Mediobanca shareholders for a vote in favour of the bid to acquire private bank Banca Generali, a document showed. The vote to be held on Aug. 21 had initially been scheduled for June 16. It was postponed as the proposal risked lacking sufficient support due to friction between the Italian merchant bank’s top management and some of its leading investors. "We continue to believe that Mediobanca shareholders should support the company’s proposal," Glass Lewis wrote in a report seen by Reuters. "We find no reason to amend our prior recommendation at this time," it added. Rival proxy adviser Institutional Shareholder Services (ISS) last week also reiterated its recommendation for a "yes" vote. Monte dei Paschi di Siena. The takeover attempt, one of a dozen M&A deals reshaping Italian banking, has opened up a battlefront between Mediobanca CEO Alberto Nagel and two top domestic shareholders who have recently also become the main investors in Monte dei Paschi. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if BMPS is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.

Investing.com -- S4 Capital PLC (LON:SFOR) said on Monday it is in early-stage discussions to acquire marketing agency MSQ Partners, a move that sent its shares soaring. The S4 Capital stock was up 8.5% in London trading as of 08:04 GMT. The digital advertising group, founded in 2018 by Martin Sorrell after his departure from WPP (LON:WPP), said MSQ is majority-owned by private equity firm One Equity Partners. It said that there is no guarantee the talks will lead to a deal. Sky News first reported the talks on Saturday. “This should be construed as a small positive for the equity today,” Jefferies analysts led by Oliver Conroy said in a note. S4 has been under pressure from client budget cuts linked to U.S. tariffs and a shift toward AI-led marketing, prompting the company to lower its revenue outlook in June. Advertising groups broadly are facing greater competition as brands demand faster adaptation to new technology. The company’s market value has plunged to about £140 million, down roughly 98% from its September 2021 peak. A tie-up with MSQ would expand S4’s reach into finance, healthcare and consumer goods, adding to a roster of more than 250 clients including Unilever (LON:ULVR), Haleon (LON:HLN), Procter & Gamble (NYSE:PG) and Lego. S4’s own client list features Google-parent Alphabet (NASDAQ:GOOGL), Amazon (NASDAQ:AMZN) and Meta (NASDAQ:META). The firm last year turned down multiple merger approaches from Stagwell, the advertising group led by former Clinton adviser Mark Penn. In June, S4 said it expects full-year like-for-like net revenue to fall by a low single-digit percentage, citing continued caution from tech clients against a backdrop of a softer global economy and U.S. tariffs. It had previously projected 2025 revenue and core operating earnings to be broadly in line with 2024 levels. The owner of the Monks agency reaffirmed its outlook for like-for-like core operating profit for the year. With GOOGL making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed GOOGL alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including GOOGL, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is GOOGL poised for similar growth? Don't miss the opportunity to find out.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

(Reuters) -The U.S. Federal Trade Commission sued to block Edwards Lifesciences Corp (NYSE:EW)’s acquisition of JenaValve Technology Inc, saying in a lawsuit filed in Washington on Wednesday the merger would decrease competition in the market for a device meant to treat a potentially fatal heart condition. Edwards and JenaValve are the only two companies in the U.S. currently conducting clinical trials on transcatheter aortic valve replacement devices, which are used to treat a condition called aortic regurgitation where the heart’s aortic valve does not close properly, the FTC said in its lawsuit. Edwards said it "disagrees with FTC’s decision and believes it will limit the availability of an important treatment option for patients suffering from aortic regurgitation." It expects a final outcome by early 2026. Edwards announced the deal in July 2024, along with its acquisition of another heart valve maker, Endotronix. The deals, together valued at approximately $1.2 billion, were aimed at expanding its portfolio of structural heart disease treatments. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is EW one of them?

(Reuters) -Skydance Media CEO David Ellison will lead the new company as chief executive after its merger with Paramount Global is completed by August 7, the independent studio said on Monday. After the deal closes, the company is expected to be structured into three primary business segments - studios, direct-to-consumer and TV media. Ellison has previously pitched a vision of Paramount as a "tech hybrid" media firm that will prioritize expanding the Paramount+ streaming service to better compete in the crowded direct-to-consumer video market. The merger was largely necessitated by the persistent decline of the traditional cable TV business as audiences rapidly abandon linear TV in favor of streaming platforms, forcing Paramount to take nearly $6 billion in write-downs on cable assets.

Investing.com -- S&P Global Ratings has raised its rating on Endo Inc. to ’BB-’ from ’B+’ and assigned a stable outlook following the completion of its merger with Mallinckrodt (OTC:MNKKQ) PLC on Friday. The rating agency subsequently withdrew its issuer credit rating on Endo, now considering it a core subsidiary of Mallinckrodt due to operational alignment with the parent company’s business and strategy. S&P also upgraded Endo’s debt instruments, raising the super-priority revolving credit facility issued by Endo Finance Holdings Inc. to ’BBB-’ from ’BB’ with a recovery rating of ’1+’, indicating expectations for full recovery in case of default. The senior secured term loan and notes were upgraded to ’BB-’ from ’B+’ with a recovery rating of ’3’, suggesting meaningful recovery of 50%-70%. While the merger moderately improves Mallinckrodt’s business strength, S&P notes that Mallinckrodt plans to divest the generics business. The company intends to spin off Par Health, a new segment containing both companies’ generics businesses, Mallinckrodt’s API business, and Endo’s sterile injectables business. This divestiture would reduce Mallinckrodt’s scale back to about $2 billion in revenues and increase product concentration, with the top three products representing approximately 62% of revenue. S&P views this planned separation as a slight credit negative due to reduced scale and diversity, though partially offset by the better growth profile and higher EBITDA margins of the remaining branded business. Key products in Mallinckrodt’s portfolio include Xiaflex and Acthar Gel, each contributing about 13% of revenue, which S&P expects to continue growing over the next few years. The agency also notes that Terlivaz, approved in September 2022, has revenue potential of $200-$300 million, though generic competition is expected by 2029. S&P identifies the absence of additional assets in the company’s branded product pipeline as a key weakness and credit risk, suggesting acquisitions will be essential for long-term viability. The stable outlook reflects S&P’s expectation that Mallinckrodt will see modest revenue growth over the next 12 months while maintaining adjusted debt to EBITDA between 2.5x and 3.5x. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.